10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Antibiotic Sensitivity refers to the susceptibility of microorganisms to antibiotics or antimicrobial drugs. This crucial aspect is determined through laboratory testing to identify the most effective treatment for bacterial infections. The process involves exposing the bacteria to different antibiotics and observing their response to ascertain which drug is most potent in inhibiting or killing the specific strain. Understanding antibiotic sensitivity is paramount in guiding healthcare professionals to prescribe the most appropriate and targeted treatment for bacterial infections. It aids in avoiding unnecessary and ineffective antibiotic usage, which contributes to the global concern of antibiotic resistance. This testing ensures that patients receive optimal therapy tailored to the specific characteristics of the infecting bacteria, promoting successful treatment outcomes and minimizing the risk of complications.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria